Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sofia Ioannou"'
Autor:
Job J. Engel, Caspar I. van der Made, Nick Keur, Todia Setiabudiawan, Rutger J. Röring, Georgia Damoraki, Helga Dijkstra, Heidi Lemmers, Sofia Ioannou, Garyfallia Poulakou, Jos W. M. van der Meer, Evangelos J. Giamarellos-Bourboulis, Vinod Kumar, Frank L. van de Veerdonk, Mihai G. Netea, Athanasios Ziogas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundDexamethasone improves the survival of COVID-19 patients in need of supplemental oxygen therapy. Although its broad immunosuppressive effects are well-described, the immunological mechanisms modulated by dexamethasone in patients hospitaliz
Externí odkaz:
https://doaj.org/article/977eca9f47a44ee89705ab85e042cda3
Autor:
Dimitrios Delialis, Georgios Georgiopoulos, Evmorfia Aivalioti, Georgios Mavraganis, Angeliki-Maria Dimopoulou, Alexandros Sianis, Lasthenis Aggelidakis, Raphael Patras, Ioannis Petropoulos, Sofia Ioannou, Rodanthi Syrigou, Sofia Chatzidou, Ioannis Kanakakis, Konstantinos Stellos, Kimon Stamatelopoulos
Publikováno v:
Hellenic Journal of Cardiology, Vol 66, Iss , Pp 26-31 (2022)
Background: Remnant cholesterol (RC) is an emerging factor contributing to residual risk for the development of atherosclerotic cardiovascular disease (ASCVD). We aimed to investigate the association of RC with ASCVD in high ASCVD risk patients. Meth
Externí odkaz:
https://doaj.org/article/7b21b9b039e448a6bbe7bab4babcd776
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101785- (2023)
Summary: Background: The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to pl
Externí odkaz:
https://doaj.org/article/849b622a96a44a189757b8aa960d5cf4
Publikováno v:
Healthcare, Vol 10, Iss 1, p 150 (2022)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been associated with a high incidence of arterial and venous thrombotic complications. However, thromboembolic events in unusual sites such as limb and visceral arterial ische
Externí odkaz:
https://doaj.org/article/80ac873863554514b561f80781911f3f
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Sympardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis
Publikováno v:
EClinicalMedicine. 56
The SAVE-MORE trial demonstrated that anakinra treatment in COVID-19 pneumonia with plasma soluble urokinase plasminogen activator (suPAR) levels of 6 ng/mL or more was associated with 0.36 odds for a worse outcome compared to placebo when expressed
Autor:
Karolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, Eirini Christaki, Simeon Metallidis, Georgios Adamis, Archontoula Fragkou, Massimo Fantoni, Aggeliki Rapti, Ioannis Kalomenidis, Georgios Chrysos, Gloria Boni, Ilias Kainis, Zoi Alexiou, Francesco Castelli, Francesco Saverio Serino, Petros Bakakos, Emanuele Nicastri, Vassiliki Tzavara, Asimina Safarika, Sofia Ioannou, Lorenzo Dagna, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Vasileios Kotsis, Andrea Angheben, George Tsoukalas, Carlo Selmi, Olga-Maria Spiropoulou, Michael Samarkos, Michael Doumas, Georgia Damoraki, Aikaterini Masgala, Ilias Papanikolaou, Aikaterini Argyraki, Marcantonio Negri, Konstantinos Leventogiannis, Styliani Symbardi, Nikolaos K. Gatselis, Vasileios Petrakis, Mihai G. Netea, Periklis Panagopoulos, Vissaria Sakka, Haralampos Milionis, George Dalekos, Evangelos Giamarellos-Bourboulis
Publikováno v:
SSRN Electronic Journal.
Autor:
Christina Traketelli, Evangelos Balis, Ilias Kainis, Athina Pyrpasopoulou, Sofia Ioannou, George Tsoukalas, Marina Koupetori, Periklis Panagopoulos, Laura Scorzolini, Karolina Akinosoglou, Alessandro Tomelleri, Brollo Lucio, Carlo Selmi, Katerina Dimakou, Haralampos J. Milionis, George N. Dalekos, Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, Maria Saridaki, Simeon Metallidis, Paola Rodari, Glykeria Tzatzagou, Charilaos Samaras, Aggeliki Rapti, Emanuele Focà, Elisabeth Kaldara, Maria Giovanna Chini, Pinelopi Grigoropoulou, Michalis Ploumidis, Maria Dafni, Matteo Bassetti, Zoi Alexiou, Efthymia Giannitsioti, Nikoletta Rovina, Aikaterini Argyraki, Francesco Vladimiro Segala, Mihai G. Netea, Ilias Papanikolaou
Publikováno v:
SSRN Electronic Journal.
Most patients infected with SARS-CoV-2 (COVID-19) experience mild, non-specific symptoms, but several develop severe symptoms associated with an excessive inflammatory response. Elevated plasma concentrations of soluble urokinase plasminogen activato
Autor:
Evangelos J. Giamarellos-Bourboulis, Garyfallia Poulakou, Aline de Nooijer, Haralampos Milionis, Simeon Metallidis, Michalis Ploumidis, Pinelopi Grigoropoulou, Aggeliki Rapti, Francesco Vladimiro Segala, Evangelos Balis, Efthymia Giannitsioti, Paola Rodari, Ilias Kainis, Zoi Alexiou, Emanuele Focà, Brollo Lucio, Nikoletta Rovina, Laura Scorzolini, Maria Dafni, Sofia Ioannou, Alessandro Tomelleri, Katerina Dimakou, Glykeria Tzatzagou, Maria Chini, Matteo Bassetti, Christina Trakatelli, George Tsoukalas, Carlo Selmi, Charilaos Samaras, Maria Saridaki, Athina Pyrpasopoulou, Elisabeth Kaldara, Ilias Papanikolaou, Aikaterini Argyraki, Karolina Akinosoglou, Marina Koupetori, Periklis Panagopoulos, George N. Dalekos, Mihai G. Netea
Publikováno v:
Cell Reports Medicine, 3, 3
Cell Reports Medicine, 3
Cell Reports Medicine, 3
Most patients infected with SARS-CoV-2 (COVID-19) experience mild, non-specific symptoms, but many develop severe symptoms associated with an excessive inflammatory response. Elevated plasma concentrations of soluble urokinase plasminogen activator r
Publikováno v:
Psychiatric Rehabilitation Journal. 27:228-234
Eight focus groups were conducted with the stakeholders involved in psychiatric foster homes: people with psychiatric disabilities, families, caregivers, and professionals. Four content dimensions emerged as important: 1) foster home environment, 2)